Epithalon

Epithalon is a peptide derived from the protein human immunodeficiency virus (HIV)-1 gp120, a key structural glycoprotein. Originally identified for its potential immunomodulatory properties in experimental settings, Epithalon has been investigated in preclinical research for its effects on cellular stress response and longevity. This product is intended solely for academic, institutional, or laboratory research purposes and is provided strictly under the supervision of qualified professionals.

Research Context

Epithalon was first described in a series of studies examining its role in the cellular stress response mechanism known as the p53 pathway. The peptide has been studied primarily in mammalian cell cultures, mouse models, and a few exploratory investigations in invertebrates, focusing on its ability to modulate oxidative stress, DNA repair, and aging-related processes. These findings remain confined to in vitro and in vivo laboratory research and have not been validated in clinical or human studies.

Research Overview

The primary research focus on Epithalon has centered on its potential mechanisms of action in the context of cellular longevity and stress resistance. Early studies suggested that Epithalon may enhance the activity of the DNA repair enzyme poly(ADP-ribose) polymerase-1 (PARP-1), which is critical for managing DNA damage induced by oxidative stress. Some investigations have also explored its effects on telomere maintenance and mitochondrial function, though results remain preliminary and are not yet universally accepted in the scientific literature.

Key Research Focus Areas

• Cellular Stress Resistance: Preliminary findings indicate that Epithalon may enhance cellular resistance to oxidative stress and DNA damage in experimental models.
• PARP-1 Modulation: Research has suggested a potential role in modulating the activity of PARP-1, a key enzyme in DNA repair mechanisms.
• Longevity-Associated Pathways: Limited studies in invertebrate models have explored whether Epithalon influences aging-related pathways, though these findings are not conclusive.
• Immunomodulation: Early investigations in cell culture systems hint at possible immunomodulatory effects, though further research is needed to clarify these interactions.
• Preclinical Models: Most of the available data come from in vitro and in vivo studies in mouse models, where Epithalon has been administered via systemic routes (e.g., intraperitoneal injection) or directly to cellular cultures.

Important Safety and Compliance Statement

This product is intended for research and academic use only. It is not approved for human or animal consumption and is provided under the strict condition that it is used exclusively in licensed research facilities by qualified professionals. No claims regarding therapeutic, cosmetic, or diagnostic efficacy have been established. Users are responsible for conducting research in compliance with all applicable laws, regulations, and institutional guidelines. Proper handling, storage, and disposal procedures must be followed at all times.

For research use only. Not for human or animal consumption.